SCHEMBL6662729

SCHEMBL6662729

Clc1cncc(Nc2cccnc2)n1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 3/20 0.72
GRM4 Q14833 1/20 0.50
KMT2A Q03164 2/20 0.45
RAD52 P43351 1/20 0.45
CSF1R P07333 1/20 0.44
NPC1 O15118 2/20 0.43
BRAF P15056 2/20 0.43
RAB9A P51151 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
INSR P06213 1/20 0.42
KDR P35968 1/20 0.42
GSK3A P49840 1/20 0.42
GSK3B P49841 1/20 0.42
CYP19A1 P11511 1/20 0.41
ADRA2A P08913 1/20 0.41
ADRA2B P18089 1/20 0.41
ADRA2C P18825 1/20 0.41
MAPK1 P28482 2/20 0.41
MAPT P10636 2/20 0.41
ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1678613 0.84 CDK2 (1.00) CDK2GRM4KMT2ACSF1RBRAF
SCHEMBL1121971 0.78 CDK2 (0.70) CDK2BRAFINSRKDRGSK3A
SCHEMBL2885798 0.77 CDK2 (0.73) CDK2GRM4NPC1BRAFRAB9A
SCHEMBL22655182 0.76 ALDH1A1 (0.66) CDK2KMT2ARAD52NPC1RAB9A
SCHEMBL6662179 0.76 CDK2 (0.66) CDK2KMT2ARAD52BRAFKDR
SCHEMBL1368828 0.74 KIF11 (0.60) KMT2ARAD52NPC1RAB9AL3MBTL1
SCHEMBL29793056 0.74 KIF11 (0.60) KMT2ARAD52NPC1RAB9AL3MBTL1
SCHEMBL18725641 0.74 TSHR (0.46) KMT2ARAD52NPC1RAB9AL3MBTL1
SCHEMBL29826892 0.74 TSHR (0.46) KMT2ARAD52NPC1RAB9AL3MBTL1
SCHEMBL6302354 0.74 CDK2 (0.69) CDK2GRM4KMT2ANPC1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004004730-A2 2-AMINOPYRAZINE DERIVATIVES AS INHIBITORS OF CYCLIN DEPENDENT KINASES FOR THE TREATMENT OF PROLIFERATIVE DISORDERS ASTEX TECHNOLOGY LIMITED (GB) 2004-01-15 WO claimed
WO-2004004730-A2 2-AMINOPYRAZINE DERIVATIVES AS INHIBITORS OF CYCLIN DEPENDENT KINASES FOR THE TREATMENT OF PROLIFERATIVE DISORDERS ASTEX TECHNOLOGY LIMITED (GB) 2004-01-15 WO disclosed